Lack of alpha1,2-fucosylation protects mice from bleomycin-induced lung fibrosis: A quantitative proteomic analysis of bronchoalveolar lavage fluid
Carbohydrate Research · 2026-09 · 567 · 110010
DOI: 10.1016/j.carres.2026.110010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carbohydrate Research, 2026-09. Verfasst von Chenxi Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Pathogen Biology, Key Laboratory of Pathogen and Host-Interactions, Ministry of Education, Tongji University School of M…. Hauptthemen laut MEDLINE: Bleomycin, Proteomics, Bronchoalveolar Lavage Fluid, Pulmonary Fibrosis. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The mechanisms responsible for pulmonary fibrosis remain incompletely understood. This study investigated the effect of alpha1,2-fucosylation deficiency on bleomycin-induced pulmonary fibrosis using wild-type C57BL/6J mice and Fut1/Fut2/Sec1 triple-knockout mice deficient in alpha1,2-fucosylation. Mice were treated with bleomycin, and lung tissues and bronchoalveolar lavage fluid (BALF) were collected on Day 7 and Day 14. DFTKO mice showed improved survival and attenuated histological lung injury and collagen deposition compared with WT mice. BALF samples were analyzed by TMT 10-plex quantitative proteomics using 18 individual samples, with three biological replicates per genotype/time-point group. Differentially expressed proteins were prioritized using combined criteria of fold change ≥1.2 or ≤0.83, P 1. In WT mice, multiple bronchoalveolar lavage proteins were elevated 7 days after bleomycin treatment, including 1) proteins involved in lipid metabolism, antimicrobial defense and inflammation: BPIFA2 (FC = 25.04, VIP = 1.22, P = 0.01), APOA1(FC = 8.37, VIP = 1.23, P = 0.02), C1QTNF5(FC = 7.72, VIP = 1.20, P = 0.049), SERPINA3N(FC = 6.64, VIP = 1.22 P = 0.4); 2) proteins involved in TGF-beta and extracellular matrix signaling: FST(FC = 14.28, VIP = 1.23, P = 0.02), BGN(FC = 13.58, VIP = 1.20, P = 0.02), TIMP1(FC = 10.72, VIP = 1.21, P = 0.04), VCAN(FC = 9.04, VIP = 1.21 P = 0.00008); 3) Collagens: COL5A1(FC = 9.63, VIP = 1.22 P = 0.01), COL5A2(FC = 7.09, VIP = 1.19 P = 0.03). Several proteins involved in detoxification of reactive oxygen species (ROS) were found to be decreased 7 days after bleomycin treatment: SELENBP1(FC = 0.18, VIP = 1.22, P = 0.02), GLRX5(FC = 0.18, VIP = 1.23, P = 0.02), UQCRC1(FC = 0.17, VIP = 1.23, P = 0.0005). In the Day 7 comparison between DFTKO and WT mice, proteins related to DNA damage repair, genome stability, wound healing, and tissue remodeling were increased in DFTKO mice, including H3C1 (FC = 3.66, VIP = 1.68, P = 0.03), SSBP1(FC = 2.96, VIP = 1.78, P = 0.0004), HMGA1(FC = 2.84, VIP = 1.60, P = 0.01), HDGFL3(FC = 3.97, VIP = 1.66, P = 0.01) and CEACAM1(FC = 2.93, VIP = 1.65, P = 0.006). These data suggest α1,2-fucosylated glycans as potential therapeutic targets for pulmonary fibrosis. Lack of alpha1,2 fucosylated structures attenuates bleomycin-induced lung fibrosis, while exact mechanisms will be focus of our future study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Pathogen Biology, Key Laboratory of Pathogen and Host-Interactions, Ministry of Education, Tongji University School of Medicine, 500 Zhennan Road, Shanghai, 200331, China.
- Department of Immunology and Pathogen Biology, Key Laboratory of Pathogen and Host-Interactions, Ministry of Education, Tongji University School of Medicine, 500 Zhennan Road, Shanghai, 200331, China. Electronic address…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Zhu, C., Jiang, Y., Mai, X., Ji, Z., Abdylla, G., & Zhou, D. (2026). Lack of alpha1,2-fucosylation protects mice from bleomycin-induced lung fibrosis: A quantitative proteomic analysis of bronchoalveolar lavage fluid. Carbohydrate Research, 567, 110010. https://doi.org/10.1016/j.carres.2026.110010
Vancouver
Zhu C, Jiang Y, Mai X, Ji Z, Abdylla G, Zhou D. Lack of alpha1,2-fucosylation protects mice from bleomycin-induced lung fibrosis: A quantitative proteomic analysis of bronchoalveolar lavage fluid. Carbohydrate Research. 2026;567:110010. doi:10.1016/j.carres.2026.110010
BibTeX
@article{Zhu2026,
author = {Zhu, Chenxi and Jiang, Yicheng and Mai, Xinjia and Ji, Zhaohui and Abdylla, Gulberdiyev and Zhou, Dapeng},
title = {Lack of alpha1,2-fucosylation protects mice from bleomycin-induced lung fibrosis: A quantitative proteomic analysis of bronchoalveolar lavage fluid},
journal = {Carbohydrate Research},
year = {2026},
volume = {567},
pages = {110010},
doi = {10.1016/j.carres.2026.110010}
}
EUVIMED